Avience Biomedicals IPO Allotment Status
SMEListedAvience Biomedicals IPO Details
Market capitalisation is the post-issue share count in the offer document’s capital structure (54,85,056 shares) multiplied by the upper end of the price band, ₹208. It is arithmetic on those two filed figures, not a valuation.
Avience Biomedicals Financials ₹ in crore
| ₹ crore | 2024 | 2025 |
|---|---|---|
| Revenue | ₹23.96 | ₹45.24 |
| Expenses | — | — |
| Net profit (PAT) | ₹2.15 | ₹7.29 |
| PAT margin | 9.0% | 16.1% |
| Total assets | ₹34.65 | ₹56.52 |
Avience Biomedicals Shareholding before & after the IPO
The founding owners and their group entities.
Post-issue pattern as filed with the NSE. Pre-issue register from the RHP capital structure, cross-checked against exchange data. Pre-issue percentages are taken from the disclosure, never estimated.
Avience Biomedicals IPO Lot Size & Minimum Investment by investor category
| Application | Shares | Amount at ₹208 |
|---|---|---|
| Individual investor (min)minimum application | 1,200 | ₹2,49,600 |
The minimum application is 1,200 shares, ₹2,49,600 at the ₹208 cut-off. Since 1 July 2025 SME issues take a minimum application of ₹2,00,000 or more from individual investors; the HNI minimum is set in the RHP. Amounts are shown at the upper band because applications are made at the cut-off price.
Avience Biomedicals IPO Strengths & Risks as disclosed in the DRHP
Strengths and risk factors from this issue’s prospectus aren’t available yet.
How to check Avience Biomedicals IPO allotment status
Allotment is decided and published by the issue’s registrar, not by the exchange and not by alphave. For Avience Biomedicals Limited, the registrar is Skyline Financial Services Pvt. Ltd. — allotment is finalised in the days between the issue closing on 22 Jun 2026 and listing on 25 Jun 2026.
Allotment and refund dates follow SEBI’s T+3 listing timeline in trading days and are tentative until the registrar and the exchange confirm them. alphave does not hold allotment results — only the registrar can show whether an application was allotted.
The registrar publishes allotment on its own portal: Skyline. Your bank will also show the blocked amount released if shares were not allotted.
Avience Biomedicals IPO Allotment Status FAQs
When is Avience Biomedicals IPO allotment date?
Allotment for the Avience Biomedicals Limited IPO is expected to be finalised on 23 June 2026, the trading day after the issue closes on 22 June 2026. Under SEBI's T+3 timeline refunds and demat credit follow on 24 June 2026 and the shares list on 25 June 2026. Dates are tentative until the registrar and exchange confirm them.
How to check Avience Biomedicals IPO allotment status?
Allotment is decided and published by the registrar, Skyline Financial Services Pvt. Ltd. — not by the exchange and not by alphave. Open the registrar's IPO allotment page, choose the issue, and enter your PAN, application number or DP ID / client ID. Your bank will also show the blocked amount released if shares were not allotted.
Who is the registrar of Avience Biomedicals IPO?
The registrar to the Avience Biomedicals Limited IPO is Skyline Financial Services Pvt. Ltd.. The registrar processes applications, finalises the basis of allotment with the exchange, and handles refunds.
What happens if I do not get allotment?
The amount blocked in your bank account under ASBA or the UPI mandate is released, normally on the day allotment is finalised or the next working day. No shares are credited and nothing further is needed from you.
Avience Biomedicals IPO Registrar where allotment and refund queries go
The registrar processes the allotment and the refunds. Contact details are as printed in the offer document; the exchange and your broker cannot change an allotment.
How to Apply for the Avience Biomedicals IPO ASBA and UPI, as SEBI sets them
- Apply through your broker’s IPO window or your bank’s net banking (ASBA). The money stays in your own account and is only blocked until allotment.
- Choose the number of lots and bid at the cut-off price. SME issues take a minimum application of two lots, so the smallest valid bid is the amount shown in the lot table above.
- If you applied through a broker, approve the UPI mandate in your payment app. The mandate must be approved by 5 pm on the day after your bid, and by 5 pm on the closing day for bids made on the last day (22 Jun 2026).
- One application per PAN. A second application under the same PAN is rejected, and both may be.
- After allotment the blocked amount is released for shares not allotted. Allotment and refund queries go to the registrar, Skyline Financial Services Pvt. Ltd., not to the exchange or the broker.
What is GMP in an IPO?
Grey Market Premium is the price at which an unlisted IPO application or share changes hands informally, before the stock is listed on the exchange. It is quoted as a rupee figure over the issue price: a premium of ₹40 on a ₹208 upper band means the grey market is dealing at issue price plus that premium.
The grey market is an over-the-counter market between private dealers. It is not operated or supervised by NSE, BSE or SEBI, no trade is settled through a clearing corporation, and no dealer is obliged to publish or honour a quote. Figures are collected by third-party reporters and different sources routinely disagree, which is why a premium can move sharply within a day or vanish entirely once bidding closes.
Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.